Real Regulatory to Attend the Good Clinical Practice Symposium 2020
Will you be at the Good Clinical Practice Symposium 2020 in London?
In partnership with the US Food and Drug Administration (FDA), this event will provide regulatory perspectives on the importance of sponsor oversight of the running of clinical trials, protocol deviations including the impact on clinical trials, and the challenges in ensuring data quality in novel clinical trial designs.
Chat with our team about how we can help you with controlling, managing and tracking clinical trial submissions on your behalf and thereby providing the tangible evidence of the trial oversight for future inspections.
To arrange a meeting at a time convenient to you, contact us today. We look forward to seeing you there!
Attendees: Dorothee Fouchier
Dorothée oversees and manages our EU office whilst providing expert consultancy input to her client projects.
Since 2003, Dorothée has gained extensive experience in the regulatory and compliance aspects of medicinal product development in Europe, including clinical trials, MAA and lifecycle management for small molecule & biotech products.